Explore the full directors' dealings record of Healthpeak Properties, INC., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Real Estate sector, Healthpeak Properties, INC. has recorded 53 insider filings. Market capitalisation: €11.2bn. The latest transaction was disclosed on 13 May 2026 — Cession. Among the most active insiders: GARVEY CHRISTINE. All data is openly available.
25 of 53 declarations
Healthpeak Properties, Inc. (NYSE: DOC) is a U.S.-listed real estate investment trust (REIT) and an S&P 500 constituent, headquartered in Denver, Colorado, United States. Founded in 1985, the company has evolved into a specialized healthcare real estate platform focused on owning, operating, and developing high-quality assets that support healthcare discovery and delivery. For investors in Europe, Healthpeak offers a distinctive listed exposure to the U.S. healthcare property market, with a portfolio and strategy that sit at the intersection of real estate, life sciences, and senior housing. Healthpeak’s business model is built around three core property themes: life science campuses and laboratory facilities, outpatient medical offices, and senior housing assets. This mix gives the company access to multiple demand drivers across the healthcare ecosystem while keeping the portfolio concentrated in specialized, hard-to-replicate real estate. In practice, Healthpeak emphasizes long-duration relationships with healthcare tenants, operational expertise, asset quality, and active capital recycling. Its competitive position comes from scale in targeted submarkets, deep sector knowledge, and the ability to redeploy capital toward higher-growth opportunities when market conditions justify it. Geographically, the portfolio is primarily U.S.-based, with notable concentration in major healthcare and innovation hubs. One of its most important life science footprints is in South San Francisco, a globally recognized biotechnology cluster. In January 2026, Healthpeak said it had completed additional transaction activity that expanded its South San Francisco portfolio and further reinforced its leadership position in that submarket. That kind of portfolio density matters in life science real estate, where tenant demand, adjacency to research ecosystems, and replacement cost barriers can all support pricing power over time. Recent corporate developments underline a more active portfolio strategy. In early 2026, Healthpeak announced the planned formation and IPO of Janus Living, a pure-play senior housing REIT, intended to unlock value from its senior housing platform and sharpen the market’s view of each business. The company also closed a new $400 million unsecured delayed-draw term loan facility in March 2026, enhancing liquidity and financial flexibility. Earlier strategic updates indicated that Healthpeak is selling stabilized outpatient medical assets and recycling capital into more strategic life science campuses, reflecting a disciplined approach to capital allocation. Healthpeak also continues to highlight operational innovation and sustainability through regular earnings updates and annual corporate impact reporting. For international investors analyzing U.S. healthcare real estate, Healthpeak stands out as a specialized, actively managed platform with a defensive income profile and selective growth exposure on the NYSE in the United States.